These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6842264)

  • 1. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.
    Limburg PC; The TH; Hummel-Tappel E; Oosterhuis HJ
    J Neurol Sci; 1983 Mar; 58(3):357-70. PubMed ID: 6842264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptor antibodies in myasthenia gravis.
    Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
    Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
    Kuks JB; Oosterhuis HJ; Limburg PC; The TH
    J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of thymoma in myasthenia gravis.
    Aarli JA
    Ital J Neurol Sci; 1983 Dec; 4(4):393-7. PubMed ID: 6370907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-acetylcholine receptor antibodies.
    Vincent A; Newsom Davis J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and features of myasthenia gravis developing after thymectomy.
    Uzawa A; Kanai T; Oda F; Ozawa Y; Yasuda M; Kawaguchi N; Himuro K; Yoshino I; Kuwabara S
    Eur J Neurol; 2020 Jan; 27(1):175-180. PubMed ID: 31347231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis with anti-acetylcholine receptor antibodies.
    Meriggioli MN
    Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different age-related effects of thymectomy in myasthenia gravis: role of thymoma, zinc, thymulin, IL-2 and IL-6.
    Mocchegiani E; Giacconi R; Muzzioli M; Gasparini N; Provinciali L; Spazzafumo L; Licastro F
    Mech Ageing Dev; 2000 Aug; 117(1-3):79-91. PubMed ID: 10958925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
    Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
    Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
    Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
    Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of thymoma in myasthenia gravis.
    Keesey J; Bein M; Mink J; Sample F; Sarti D; Mulder D; Herrmann C; Peter JB
    Neurology; 1980 Mar; 30(3):233-9. PubMed ID: 7189022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart muscle antibodies in myasthenia gravis.
    Mygland A; Aarli JA; Hofstad H; Gilhus NE
    Autoimmunity; 1991; 10(4):263-7. PubMed ID: 1772962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
    Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
    J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.